Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68632 |
| ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2020-07-16 | 2020-11-07 | 120494 |
| ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2022-11-14 | 2023-02-09 | 174607 |
| ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2023-02-16 | 2023-06-09 | 184937 |
| ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2023-06-20 | 2023-07-28 | 195789 |
| FENTORA | 200MCG | TABLET (EFFERVESCENT) | Resolved | 2018-03-13 | 2018-07-30 | 42638 |
| FENTORA | 400MCG | TABLET (EFFERVESCENT) | Resolved | 2019-06-27 | 2019-08-29 | 87668 |
| FENTORA | 800MCG | TABLET (EFFERVESCENT) | Resolved | 2019-08-22 | 2019-10-04 | 92143 |
| FENTORA | 100MCG | TABLET (EFFERVESCENT) | Resolved | 2020-11-19 | 2021-02-05 | 128600 |
| FENTORA | 200MCG | TABLET (EFFERVESCENT) | Resolved | 2021-01-28 | 2021-02-05 | 132630 |
| FENTORA | 600MCG | TABLET (EFFERVESCENT) | Resolved | 2021-03-04 | 2021-03-18 | 135114 |
| FENTORA | 200MCG | TABLET (EFFERVESCENT) | Resolved | 2021-07-08 | 2021-10-14 | 142198 |
| FENTORA | 400MCG | TABLET (EFFERVESCENT) | Resolved | 2021-09-23 | 2021-10-28 | 146115 |
| FENTORA | 800MCG | TABLET (EFFERVESCENT) | Resolved | 2021-09-23 | 2021-10-28 | 146125 |
| FENTORA | 400MCG | TABLET (EFFERVESCENT) | Resolved | 2023-04-27 | 2023-06-21 | 190698 |
| FENTORA | 600MCG | TABLET (EFFERVESCENT) | Resolved | 2023-06-08 | 2023-10-04 | 194172 |
| FENTORA | 600MCG | TABLET (EFFERVESCENT) | Resolved | 2023-06-19 | 2023-07-05 | 195548 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2018-08-21 | 2018-11-08 | 58634 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-02-05 | 2019-03-12 | 74792 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-06-03 | 2019-08-07 | 85468 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |